Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hammond

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Diabetes Research and Clinical Practice|February 28, 2024
Real-world outcomes of Omnipod DASH system use in people with type 1 diabetes: Evidence from the Association of British Clinical Diabetologists (ABCD) studyAlexandros L Liarakos, Nebras Hasan, Thomas S J Crabtree, et al.
Plos One|September 1, 2012
Ethanol-induced face-brain dysmorphology patterns are correlative and exposure-stage dependentRobert J Lipinski, Peter Hammond, Shonagh K O'Leary-Moore, et al.
American Journal of Human Genetics|May 5, 2009
Frontorhiny, a distinctive presentation of frontonasal dysplasia caused by recessive mutations in the ALX3 homeobox geneStephen R F Twigg, Sarah L Versnel, Gudrun Nürnberg, et al.
Pediatric Blood & Cancer|May 30, 2023
Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans-Atlantic, multicenter cross-sectional cohort studyMarinka L F Hol, Daniel J Indelicato, Olga Slater, et al.
American Journal of Human Genetics|December 29, 2005
Discriminating power of localized three-dimensional facial morphologyPeter Hammond, Tim J Hutton, Judith E Allanson, et al.
Diabetes Care|August 11, 2023
Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational StudyThomas S J Crabtree, Tomás P Griffin, Yew W Yap, et al.
American Journal of Medical Genetics. Part A|April 17, 2008
Molecular aspects, clinical aspects and possible treatment modalities for Costello syndrome: Proceedings from the 1st International Costello Syndrome Research Symposium 2007Katherine A Rauen, Erin Hefner, Kristin Carrillo, et al.
American Journal of Medical Genetics. Part A|February 21, 2018
Further delineation of an entity caused by CREBBP and EP300 mutations but not resembling Rubinstein-Taybi syndromeLeonie A Menke, , Thatjana Gardeitchik, et al.
Health Technology Assessment (Winchester, England)|April 26, 2017
A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE TrialSimon Heller, David White, Ellen Lee, et al.
Nature Genetics|January 29, 2013
Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesisStephen R F Twigg, Elena Vorgia, Simon J McGowan, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Diabetes Research and Clinical Practice|February 28, 2024
Real-world outcomes of Omnipod DASH system use in people with type 1 diabetes: Evidence from the Association of British Clinical Diabetologists (ABCD) studyAlexandros L Liarakos, Nebras Hasan, Thomas S J Crabtree, et al.
Plos One|September 1, 2012
Ethanol-induced face-brain dysmorphology patterns are correlative and exposure-stage dependentRobert J Lipinski, Peter Hammond, Shonagh K O'Leary-Moore, et al.
American Journal of Human Genetics|May 5, 2009
Frontorhiny, a distinctive presentation of frontonasal dysplasia caused by recessive mutations in the ALX3 homeobox geneStephen R F Twigg, Sarah L Versnel, Gudrun Nürnberg, et al.
Pediatric Blood & Cancer|May 30, 2023
Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans-Atlantic, multicenter cross-sectional cohort studyMarinka L F Hol, Daniel J Indelicato, Olga Slater, et al.
American Journal of Human Genetics|December 29, 2005
Discriminating power of localized three-dimensional facial morphologyPeter Hammond, Tim J Hutton, Judith E Allanson, et al.
Diabetes Care|August 11, 2023
Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational StudyThomas S J Crabtree, Tomás P Griffin, Yew W Yap, et al.
American Journal of Medical Genetics. Part A|April 17, 2008
Molecular aspects, clinical aspects and possible treatment modalities for Costello syndrome: Proceedings from the 1st International Costello Syndrome Research Symposium 2007Katherine A Rauen, Erin Hefner, Kristin Carrillo, et al.
American Journal of Medical Genetics. Part A|February 21, 2018
Further delineation of an entity caused by CREBBP and EP300 mutations but not resembling Rubinstein-Taybi syndromeLeonie A Menke, , Thatjana Gardeitchik, et al.
Health Technology Assessment (Winchester, England)|April 26, 2017
A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE TrialSimon Heller, David White, Ellen Lee, et al.
Nature Genetics|January 29, 2013
Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesisStephen R F Twigg, Elena Vorgia, Simon J McGowan, et al.
Pageof 8